We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    fibrosing colonopathy
Previous Study | Return to List | Next Study

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

This study is currently recruiting participants.
Verified November 2017 by AbbVie ( AbbVie (prior sponsor, Abbott) )
Sponsor:
ClinicalTrials.gov Identifier:
NCT01652157
First Posted: July 27, 2012
Last Update Posted: November 30, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborators:
Cystic Fibrosis Foundation Therapeutics
Digestive Care, Inc.
Janssen Research & Development, LLC
Forest Research Institute, Inc., an Allergan affiliate
Information provided by (Responsible Party):
AbbVie ( AbbVie (prior sponsor, Abbott) )
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 29, 2022
  Estimated Primary Completion Date: July 29, 2022 (Final data collection date for primary outcome measure)